This HTML5 document contains 72 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q64611307
rdf:type
wikibase:Item
schema:description
clinical trial клінічне випробування ensayu clínicu klinisch onderzoek
rdfs:label
RCT Meropenem vs Piperacillin-Tazobactam for Definitive Treatment of BSI's Due to Ceftriaxone Non-susceptible Escherichia Coli and Klebsiella Spp.
skos:prefLabel
RCT Meropenem vs Piperacillin-Tazobactam for Definitive Treatment of BSI's Due to Ceftriaxone Non-susceptible Escherichia Coli and Klebsiella Spp.
schema:name
RCT Meropenem vs Piperacillin-Tazobactam for Definitive Treatment of BSI's Due to Ceftriaxone Non-susceptible Escherichia Coli and Klebsiella Spp.
p:P1476
wds:Q64611307-22506113-9349-4A43-9562-51C36C24A3A9
wdt:P1476
Randomized Controlled Trial of Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Due to Ceftriaxone Non-susceptible E. Coli and Klebsiella Species.
p:P582
wds:Q64611307-7B7F33EA-15F3-4A1C-B7AB-9ADA3EB3F00D
wdt:P582
2017-07-07T00:00:00Z
p:P31
wds:Q64611307-88999EF3-E7BE-419F-B583-EC61C832F288
wdt:P31
wd:Q30612
p:P580
wds:Q64611307-66EDCD85-E080-4B1F-8FAD-EB25B787F101
wdt:P580
2014-02-01T00:00:00Z
p:P17
wds:Q64611307-ECAD7269-7003-4F30-8B8A-CA21FBF01973 wds:Q64611307-FD71907D-E619-4D38-9FE5-191ECFAD910B wds:Q64611307-E2F97F93-7925-46F5-8A85-361E8EBB8008 wds:Q64611307-A6E05F82-E8B2-4F26-90D6-7EF41D34FBC9 wds:Q64611307-5C3EBD6D-FC09-4E89-BDA6-24783BEE78DE wds:Q64611307-7489BFA2-1616-4944-ACC6-69DBDB5E02ED wds:Q64611307-1F8F6E18-14C7-45F0-9CBE-0F9430B44B27 wds:Q64611307-4C1D4BA0-35A8-4062-ACBC-DDC1291C89F5 wds:Q64611307-31FEE0B2-160A-4347-95C2-15F1CDD3C3B5
wdt:P17
wd:Q258 wd:Q334 wd:Q38 wd:Q16 wd:Q43 wd:Q851 wd:Q822 wd:Q408 wd:Q664
p:P6153
wds:Q64611307-B6962114-8C03-4CC2-BDF3-026A3AB942A4 wds:Q64611307-BB7654FF-33A4-40F3-A329-37739FDA678F wds:Q64611307-BCAD1E1B-AEEC-443B-8833-90C410694E7D wds:Q64611307-35A5808D-B511-4A82-AE67-12A7C413BE81 wds:Q64611307-3F008D9B-37D8-4B1D-9915-1B3FCDB13675 wds:Q64611307-068B6DAD-B67F-4A74-ADC8-7E9226C7E004 wds:Q64611307-2DF7670F-D645-4696-AE61-F39BD0237108 wds:Q64611307-70DD50A1-79F0-4238-807F-8E683901C792 wds:Q64611307-5369AE8D-F61A-4B68-B73A-FC8574F19175 wds:Q64611307-5DA80BC0-2335-4D95-A500-8264AE747A3A
wdt:P6153
wd:Q7713086 wd:Q6979219 wd:Q50573098 wd:Q7989074 wd:Q598841 wd:Q7640792 wd:Q4865987 wd:Q1517021 wd:Q7682145 wd:Q5451115
p:P1813
wds:Q64611307-D3F985B2-4E76-47F7-AF9D-E64A6F407F27
wdt:P1813
MERINO
p:P4844
wds:Q64611307-60266557-D9AE-44AD-BAAF-D23B45E43AFA wds:Q64611307-B335E410-FBE5-4139-9FD2-1615765A2871
wdt:P4844
wd:Q421670 wd:Q421713
p:P2899
wds:Q64611307-8682AB52-9CB3-48B2-9433-697D11A5372D
wdt:P2899
18
p:P1132
wds:Q64611307-8F708FFF-F9F7-455B-BBA4-621D9D2BEAE1
wdt:P1132
391
p:P767
wds:Q64611307-97518080-C36F-4C3F-9863-22363209DB0E
wdt:P767
wd:Q50035906
p:P8363
wds:Q64611307-694EE448-41B0-49DB-BDDE-335AD15D7674
wdt:P8363
wd:Q78089383
p:P3098
wds:Q64611307-BD044A9D-69BB-4C35-B1D3-BF6DB756F639
wdt:P3098
NCT02176122
p:P6099
wds:Q64611307-8C170B71-55CE-4983-BF27-FC4577729B6D
wdt:P6099
wd:Q42825046